Status:
COMPLETED
Effects of Preemptive Paracetamol and Ibuprofen on Headache and Myalgia in Patients After Electroconvulsive Therapy
Lead Sponsor:
Inonu University
Conditions:
Postoperative Pain
Myalgia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The primary aim this prospective, randomized, double-blind, placebo-controlled clinical trial is to compare the analgesic effects of preemptive intravenous paracetamol and ibuprofen on headache and my...
Detailed Description
Electroconvulsive therapy (ECT) is one of the effective and life-saving treatment modality used in psychiatry for a long time because it responds more rapidly than pharmacological treatment. ECT is us...
Eligibility Criteria
Inclusion
- Patients with major depression
- Patients with American Society of Anesthesiologists (ASA) scores I or II
- Between 18-65
Exclusion
- Patients with ASA scores III/IV,
- Under the age of 18,
- Over the age of 65,
- Myocardial infarction,
- Congestive heart failure,
- Pulmonary disease,
- Stroke history,
- Bleeding disorder,
- Hepatic and renal dysfunction,
- Pregnant,
- Migraine history,
- Allergy of nonsteroidal anti-inflammatory drugs, paracetamol, propofol,
- Neuromuscular disease,
- Peptic ulcer disease,
- Intracranial hypertension,
- Glaucoma
- Patients who did not give informed consent
Key Trial Info
Start Date :
December 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 10 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03783312
Start Date
December 20 2018
End Date
February 10 2019
Last Update
April 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erol Karaaslan
Malatya, Türkiye-Türkçe, Turkey (Türkiye), 44090